StockData

Nu-Med Plus, Inc. (NUMD) stock

NUMDOTCGold and Silver OresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.01−0.00 (-8.16%)

Close on Oct 19, 2026Market cap $601.55KP/E –Yield –

Nu-Med Plus operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Nu-Med Plus's operating income for the twelve months ending Jun 30, 2026 was -$55.54K. For fiscal 2025 it was -$48.96K. The highest annual figure on record is -$48.96K in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$48.96K–
FY2024Dec 31, 2024-$63.33K–
FY2023Dec 31, 2023-$120.53K–
FY2022Dec 31, 2022-$182.17K–
FY2021Dec 31, 2021-$839.45K–
FY2020Dec 31, 2020-$1.99M–
FY2019Dec 31, 2019-$1.02M–
FY2018Dec 31, 2018-$1.17M–
FY2017Dec 31, 2017-$466.52K–
FY2016Dec 31, 2016-$1.22M–
FY2015Dec 31, 2015-$946.48K–
FY2014Dec 31, 2014-$1.15M–
FY2013Dec 31, 2013-$233.64K–
FY2012Dec 31, 2012-$258.23K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$22.56K–
Q1 FY2026Mar 31, 2026-$13.15K–
Q4 FY2025Dec 31, 2025-$9.76K–
Q3 FY2025Sep 30, 2025-$10.08K–
Q2 FY2025Jun 30, 2025-$10.42K–
Q1 FY2025Mar 31, 2025-$18.70K–
Q4 FY2024Dec 31, 2024-$9.29K–
Q3 FY2024Sep 30, 2024-$17.42K–
Q2 FY2024Jun 30, 2024-$16.04K–
Q1 FY2024Mar 31, 2024-$20.58K–
Q4 FY2023Dec 31, 2023-$55.34K–
Q3 FY2023Sep 30, 2023-$15.15K–
Q2 FY2023Jun 30, 2023-$23.07K–
Q1 FY2023Mar 31, 2023-$26.97K–
Q4 FY2022Dec 31, 2022-$6.39K–
Q3 FY2022Sep 30, 2022-$58.05K–
Q2 FY2022Jun 30, 2022-$58.07K–
Q1 FY2022Mar 31, 2022-$59.65K–
Q4 FY2021Dec 31, 2021-$112.34K–
Q3 FY2021Sep 30, 2021-$118.37K–
Q2 FY2021Jun 30, 2021-$251.99K–
Q1 FY2021Mar 31, 2021-$356.75K–
Q4 FY2020Dec 31, 2020-$491.16K–
Q3 FY2020Sep 30, 2020-$449.76K–
Q2 FY2020Jun 30, 2020-$904.45K–
Q1 FY2020Mar 31, 2020-$149.31K–
Q4 FY2019Dec 31, 2019-$205.70K–
Q3 FY2019Sep 30, 2019-$146.21K–
Q2 FY2019Jun 30, 2019-$243.79K–
Q1 FY2019Mar 31, 2019-$423.73K–
Q4 FY2018Dec 31, 2018-$335.97K–
Q3 FY2018Sep 30, 2018-$522.07K–
Q2 FY2018Jun 30, 2018-$168.71K–
Q1 FY2018Mar 31, 2018-$142.56K–
Q2 FY2017Jun 30, 2017-$111.30K–
Q1 FY2017Mar 31, 2017-$69.73K–

More Nu-Med Plus figures

See a number that looks wrong?